• address CMMI payment models like the RO Model and prior authorization process for Medicare beneficiaries
• Address payment models that impact reimbursement for proton therapy and prior authorization processes for Medicare beneficiaries
• Prior Auth issues for proton therapy and cancer patients, bundled payment models, value of proton therapy for cancer patients and importance of access for patients,
• Address concerns regarding prior authorization processes for cancer patients

Duration: July 1, 2021 to present

General Issues: Medicare/Medicaid, Budget/Appropriations, Health Issues, Insurance, Medical/Disease Research/Clinical Labs

Spending: about $0 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2021: House of Representatives, U.S. Senate, Centers For Medicare and Medicaid Services (CMS)